DK320287D0 - PROCEDURE FOR USING BARL FOR Separation of Alien Proteins - Google Patents

PROCEDURE FOR USING BARL FOR Separation of Alien Proteins

Info

Publication number
DK320287D0
DK320287D0 DK320287A DK320287A DK320287D0 DK 320287 D0 DK320287 D0 DK 320287D0 DK 320287 A DK320287 A DK 320287A DK 320287 A DK320287 A DK 320287A DK 320287 D0 DK320287 D0 DK 320287D0
Authority
DK
Denmark
Prior art keywords
barl
alien
proteins
separation
procedure
Prior art date
Application number
DK320287A
Other languages
Danish (da)
Other versions
DK320287A (en
Inventor
Vivian L Mackay
Original Assignee
Vivian L Mackay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vivian L Mackay filed Critical Vivian L Mackay
Publication of DK320287D0 publication Critical patent/DK320287D0/en
Publication of DK320287A publication Critical patent/DK320287A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
    • C12N9/60—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK320287A 1985-10-25 1987-06-23 PROCEDURE FOR USING BARL FOR Separation of Alien Proteins DK320287A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79130585A 1985-10-25 1985-10-25
PCT/US1986/002198 WO1987002670A1 (en) 1985-10-25 1986-10-20 Method of using bar1 for secreting foreign proteins

Publications (2)

Publication Number Publication Date
DK320287D0 true DK320287D0 (en) 1987-06-23
DK320287A DK320287A (en) 1987-06-23

Family

ID=25153298

Family Applications (1)

Application Number Title Priority Date Filing Date
DK320287A DK320287A (en) 1985-10-25 1987-06-23 PROCEDURE FOR USING BARL FOR Separation of Alien Proteins

Country Status (13)

Country Link
EP (1) EP0243465A1 (en)
JP (1) JP2523562B2 (en)
CN (1) CN1027179C (en)
AU (2) AU6543286A (en)
CA (1) CA1316133C (en)
CZ (1) CZ284251B6 (en)
DK (1) DK320287A (en)
FI (1) FI872801A0 (en)
HU (1) HU206897B (en)
IE (1) IE63822B1 (en)
SK (1) SK279041B6 (en)
UA (1) UA41863C2 (en)
WO (1) WO1987002670A1 (en)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK58285D0 (en) * 1984-05-30 1985-02-08 Novo Industri As PEPTIDES AND MANUFACTURING AND USING THEREOF
DE3887425T2 (en) * 1987-10-02 1994-06-23 Zymogenetics Inc BAR1 secretion signal sequence.
US5206699A (en) * 1988-05-06 1993-04-27 Gersan Establishment Sensing a narrow frequency band of radiation and gemstones
KR100195632B1 (en) * 1988-07-23 1999-06-15 스티븐 조지 가랜드 New secretory leader sequences
WO1991013971A1 (en) * 1990-03-13 1991-09-19 Hawaii Biotechnology Group, Inc. Neurospora expression system
DK82893D0 (en) * 1993-07-08 1993-07-08 Novo Nordisk As PEPTIDE
JP3360830B2 (en) 1995-03-17 2003-01-07 ノボザイムス アクティーゼルスカブ Novel endoglucanase
CA2246733C (en) 1996-03-01 2010-07-20 Novo Nordisk A/S Use of a pharmaceutical composition comprising an appetite-suppressing peptide
HUP0203751A3 (en) 2000-01-10 2005-01-28 Maxygen Holdings Ltd Redwood C G-csf conjugates
ATE428445T1 (en) 2000-02-11 2009-05-15 Bayer Healthcare Llc CLOTTING FACTOR VII OR VIIA CONJUGATES
RU2003128955A (en) 2001-02-27 2005-04-10 Максиген Апс (Dk) NEW INTERFERON BETA-LIKE MOLECULES
JP2004529640A (en) 2001-03-22 2004-09-30 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト Coagulation factor VII derivative
US6534059B2 (en) 2001-06-05 2003-03-18 Advanced Biotherapy, Inc. Compositions and methods for treating hyperimmune response in the eye
PL368619A1 (en) 2001-09-27 2005-04-04 Novo Nordisk Health Care Ag Human coagulation factor vii polypeptides
CN1863908B (en) 2003-09-09 2010-08-04 诺和诺德医疗保健公司 Coagulation factor vii polypeptides
DE602006020032D1 (en) 2005-04-18 2011-03-24 Novo Nordisk As IL-21 VARIANTS
ES2368500T3 (en) 2005-08-16 2011-11-17 Novo Nordisk A/S METHOD FOR PRODUCING MATURE INSULIN POLYPEPTIDES.
US20090055942A1 (en) 2005-09-14 2009-02-26 Novo Nordisk Healthcare A/G Human Coagulation Factor VII Polypeptides
WO2007103447A2 (en) 2006-03-06 2007-09-13 Humagene, Inc. A method for the preparation of recombinant human thrombin
DK2615108T3 (en) 2006-09-08 2017-01-30 Ambrx Inc Modified human plasma polypeptide or fc scaffolds and their applications
ES2464282T3 (en) 2006-09-27 2014-06-02 Novo Nordisk A/S Method for preparing mature insulin polypeptides
US8114630B2 (en) 2007-05-02 2012-02-14 Ambrx, Inc. Modified interferon beta polypeptides and their uses
NZ584825A (en) 2007-11-20 2013-03-28 Ambrx Inc Modified insulin polypeptides and their uses
CN102159230A (en) 2008-07-23 2011-08-17 Ambrx公司 Modified bovine g-csf polypeptides and their uses
US8349325B2 (en) 2008-12-23 2013-01-08 Abbott Laboratories Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making
WO2010103038A1 (en) 2009-03-11 2010-09-16 Novo Nordisk A/S Interleukin-21 variants having antagonistic binding to the il-21 receptor
AU2010272483B2 (en) 2009-07-17 2016-07-21 Omeros Corporation MASP isoforms as inhibitors of complement activation
WO2011067283A1 (en) 2009-12-01 2011-06-09 Novo Nordisk A/S Novel peptidyl alpha-hydroxyglycine alpha-amidating lyases
KR20120123365A (en) 2009-12-21 2012-11-08 암브룩스, 인코포레이티드 Modified porcine somatotropin polypeptides and their uses
CA2784793A1 (en) 2009-12-21 2011-07-21 Ambrx, Inc. Modified bovine somatotropin polypeptides and their uses
CA2791841C (en) 2010-03-05 2023-01-03 Rigshospitalet Chimeric inhibitor molecules of complement activation
US20110229921A1 (en) 2010-03-18 2011-09-22 Abbott Laboratories METHODS OF ASSAYING URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (uNGAL) IN THE PROGNOSIS OF CADAVERIC KIDNEY TRANSPLANT FUNCTION IN A PATIENT, INCLUDING A PATIENT DIAGNOSED WITH DELAYED GRAFT FUNCTION (DGF), A METHOD OF ASSAYING uNGAL IN THE ASSESSMENT OF RISK OF DGF IN A PATIENT DIAGNOSED WITH EARLY GRAFT FUNCTION (EGF), AND RELATED KITS
US9551714B2 (en) 2010-06-25 2017-01-24 Abbott Laboratories Materials and methods for assay of anti-hepatitis C virus (HCV) antibodies
FI3572091T3 (en) 2010-08-17 2024-03-01 Ambrx Inc Modified relaxin polypeptides and their uses
AR083006A1 (en) 2010-09-23 2013-01-23 Lilly Co Eli FORMULATIONS FOR THE STIMULATING FACTOR OF COLONIES OF GRANULOCITS (G-CSF) BOVINE AND VARIANTS OF THE SAME
US20120115244A1 (en) 2010-11-09 2012-05-10 Abbott Laboratories Materials and methods for immunoassay of pterins
CA2819552C (en) 2010-12-09 2023-09-26 Institut Pasteur Mgmt-based method for obtaining high yield of recombinant protein expression
JP6215223B2 (en) 2011-12-09 2017-10-18 アンスティテュ・パストゥール Multiplex immunoscreening assay
US8993248B2 (en) 2011-12-31 2015-03-31 Abbott Laboratories Truncated human vitamin D binding protein and mutation and fusion thereof and related materials and methods of use
US11787844B2 (en) 2012-02-09 2023-10-17 Var2 Pharmaceuticals Aps Targeting of chondroitin sulfate glycans
US20150307865A1 (en) 2012-10-15 2015-10-29 Novo Nordisk Health Care Ag Coagulation factor vii polypeptides
JP2014128262A (en) * 2012-11-27 2014-07-10 Kirin Brewery Co Ltd Screening method for yeast strains having conjugative ability
WO2019213331A1 (en) 2018-05-01 2019-11-07 Ambrx, Inc. A method for optimizing antibody expression
US20210278406A1 (en) 2018-07-13 2021-09-09 Varct Diagnostic Aps Isolation of circulating cells of fetal origin using recombinant malaria protein var2csa
EP3849614B1 (en) 2018-09-11 2023-12-20 Ambrx, Inc. Interleukin-2 polypeptide conjugates and their uses
EP3867265A1 (en) 2018-10-19 2021-08-25 Ambrx, Inc. Interleukin-10 polypeptide conjugates, dimers thereof, and their uses
WO2020168017A1 (en) 2019-02-12 2020-08-20 Ambrx, Inc. Compositions containing, methods and uses of antibody-tlr agonist conjugates
JP2023517595A (en) 2020-03-11 2023-04-26 アンブルックス，インコーポレイテッド Interleukin-2 polypeptide conjugates and methods of use thereof
WO2021211331A1 (en) 2020-04-13 2021-10-21 Abbott Point Of Care Inc. METHODS, COMPLEXES AND KITS FOR DETECTING OR DETERMINING AN AMOUNT OF A ß-CORONAVIRUS ANTIBODY IN A SAMPLE
KR20230042301A (en) 2020-08-04 2023-03-28 애벗트 라보라토리이즈 Improved methods and kits for detecting SARS-COV-2 proteins in samples
CA3190606A1 (en) 2020-08-20 2022-02-24 Ambrx, Inc. Antibody-tlr agonist conjugates, methods and uses thereof
WO2022147147A1 (en) 2020-12-30 2022-07-07 Abbott Laboratories Methods for determining sars-cov-2 antigen and anti-sars-cov-2 antibody in a sample
IL307282A (en) 2021-04-03 2023-11-01 Ambrx Inc Anti-her2 antibody-drug conjugates and uses thereof
CN115806889B (en) * 2022-09-28 2024-06-11 山东大学 Saccharomyces cerevisiae engineering bacteria for improving gene expression level and construction method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4546082A (en) * 1982-06-17 1985-10-08 Regents Of The Univ. Of California E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins
US4613572A (en) * 1983-08-15 1986-09-23 Kansas State University Research Foundation Yeast BAR1 gene plasmid
DE3537176C2 (en) * 1984-10-18 1994-06-09 Zymogenetics Inc Tissue plasminogen activator and process for its manufacture
JPS61247384A (en) * 1984-10-18 1986-11-04 チモ−ジエネテイツクス　インコ−ポレ−テツド Development of plasminogen activating factor in yeast

Also Published As

Publication number Publication date
CA1316133C (en) 1993-04-13
JP2523562B2 (en) 1996-08-14
EP0243465A1 (en) 1987-11-04
FI872801A (en) 1987-06-24
CN86107554A (en) 1987-08-26
UA41863C2 (en) 2001-10-15
HUT43624A (en) 1987-11-30
SK776486A3 (en) 1998-06-03
SK279041B6 (en) 1998-06-03
CZ284251B6 (en) 1998-10-14
HU206897B (en) 1993-01-28
FI872801A0 (en) 1987-06-24
DK320287A (en) 1987-06-23
CN1027179C (en) 1994-12-28
WO1987002670A1 (en) 1987-05-07
AU7400391A (en) 1991-07-18
AU676132B2 (en) 1997-03-06
IE63822B1 (en) 1995-06-14
JPS63501614A (en) 1988-06-23
AU6543286A (en) 1987-05-19
CZ776486A3 (en) 1996-09-11
IE862804L (en) 1987-04-25

Similar Documents

Publication Publication Date Title
DK320287D0 (en) PROCEDURE FOR USING BARL FOR Separation of Alien Proteins
DK174484D0 (en) PROCEDURE FOR CHROMATOGRAPHIC FRACTIONING OF PLASMA PROTEINS
DK101588D0 (en) PROCEDURE FOR OLIGOMERIZATION OF OLEPHINES
DK515789A (en) PROCEDURE FOR SEPARATION OF FOLIC ACID
DK129085D0 (en) PROCEDURE FOR THE PRODUCTION OF PROTEINS
DK431485D0 (en) MUTUAL SEPARATION OF PROTEINS
DK260186A (en) PROCEDURE FOR REMOVAL OF N-TERMINAL METIONIN FROM METIONYL PROTEINS
DK165250C (en) METHOD OF PREPARING 2-AMINO-6-CHLORPURINE
DK47684D0 (en) PROCEDURE FOR THE PREPARATION OF PROTEIN HYDROOLYCATES
DK296485D0 (en) PROCEDURE FOR THE PREPARATION OF L-PHENYLALANINE
DK268186A (en) PROCEDURE FOR MAKING ISATIN RELATIONS
DK78784A (en) PROCEDURE FOR SEPARATION OF SOLUTIONS
DK453586A (en) METHOD OF PREPARING 4-HYDROXY-2-OXO-PYRROLIDIN-1-YL-ACETAMIDE
DK71683D0 (en) PROCEDURE FOR THE PREPARATION OF PROTEIN FOR HYDROLYSE
DK258886A (en) PROCEDURE FOR THE PREPARATION OF ALKYLOXIRANES
DK210586D0 (en) PROCEDURE FOR COMPOSITIONING OF PIPE-PLASTIC PLASTICS
DK509986A (en) PROCEDURE FOR THE PREPARATION OF ARYL-CYANAMIDES
DK354585D0 (en) PROCEDURE FOR THE PREPARATION OF THE TERPIN-4 OLES
DK163830C (en) PROCEDURE FOR THE PREPARATION OF RIBOFLAVIN
DK390887D0 (en) PROCEDURE FOR THE PREPARATION OF 7ALFA ACETYLTHIOSTEROIDS
DK61091D0 (en) PROCEDURE FOR THE PREPARATION OF 4-PHENYLPIPERIDE INGREDIATES
DK98792D0 (en) PROCEDURE FOR THE MANUFACTURE OF OXETANONES
DK546384A (en) PROCEDURE FOR RECOGNITION OF SIGNS
DK28386D0 (en) PREPARATION OF PEPTIDES
DK393883D0 (en) PROCEDURE FOR FRACTIONING OF PURPOSES

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment